EU PHARMA SECTOR SCRAMBLING TO RESPOND TO BREXIT REFERENDUM RESULT
June 1st, 2016
THE EUROPEAN and British pharmaceutical industries are being faced with taking swift action to deal with the impact of the UK referendum vote last week (June 23) to leave the European Union (EU), a move opposed by most medicine manufacturers.
The Association of the British Pharmaceutical Industry (ABPI) quickly responded, with CEO Mike Thompson declaring: “The voice of the British people has been heard. This creates immediate challenges for future investment, research and jobs in our industry in the UK. With that being the case, we are committed to working ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.